| Name | Title | Contact Details |
|---|
Patient populations deserve better care. We believe this is possible when physicians are empowered with actionable real-time data to make the most informed medical decisions possible. Alio Medical is medical technology company focused on providing peace of mind to dialysis patients through advanced remote monitoring. Alio provides wireless, remote, noninvasive monitoring of end stage kidney disease (ESKD) patients undergoing hemodialysis. Alio monitors dialysis patient blood flow by capturing and transmitting multimodal sensor data at regular intervals using quantitative analysis of optical, mechanical, acoustic, and thermal data related to blood flow and the composition of the blood itself. Alio remote monitoring utilizes a wearable device, the SmartPatch, placed over the patient`s vascular access graft to gather data and transmit it to a Hub located in the patient`s home. The Hub relays this raw data to the Alio Cloud where it is processed and analyzed utilizing Alio`s proprietary algorithms, developed using data collected pre- and post-dialysis in clinical centers in the US and UK. Alio clinically actionable data is accessed by the clinical team via a web-based data portal and the clinical team is alerted if an abnormality in any of a patient`s metrics is detected. Alio is designed to allow the dialysis patient healthcare team to partner effectively and enjoy simpler care coordination as well as more effective management of their patient`s health.
Medical Supply Corporation is a Ferndale, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Canadian Generic Pharmaceutical Association is a North York, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Bloodstream infection leading to sepsis is responsible for more than half of all deaths in hospitals and is the most expensive condition treated in hospitals. Mortality rate increases 6% every hour from onset. Therefore, it is critical the right antibiotic treatment is determined quickly. Current methodologies require 3 days to determine the effective antibiotic. Specific Diagnostics has developed a new technology that determines the effective antibiotic in less than 1 day. Specific`s Reveal™ instrument and assay are cost effective and labor-saving allowing clinics to readily deploy the Specific Reveal solution. Specific`s unique patented technology leverages a low-cost small molecule sensor (SMS) array, enabling diagnostic products that simplify workflow and speed time-to-answer at low cost. Specific`s system streamlines lab workflow, reduce costs, and substantially shorten the time from sample arrival to selection of effective therapy, saving patients faced with fast-moving and deadly drug-resistant blood infections. Specific and its founders have written almost 60 peer-reviewed publications, detailing the successful demonstration of the SMS array technology. The Company itself has independently authored over 20 scientific publications and conference abstracts detailing the SMS array powered detection, identification and antibiotic susceptibility testing.
Prevtec Microbia Inc. is a Saint-Hyacinthe, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.